Trial Profile
A prospective and naturalistic study to evaluate the efficacy and acceptability in the treatment of manic episodes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Asenapine (Primary)
- Indications Bipolar disorders; Schizoaffective disorder
- Focus Therapeutic Use
- 21 Dec 2015 New trial record